Related Experiment Video
Updated: Jun 13, 2026
09:34
Reprogramming Primary Amniotic Fluid and Membrane Cells to Pluripotency in Xeno-free Conditions
Published on: November 27, 2017
Induced pluripotent stem cells: what lies beyond the paradigm shift
1Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, 986805 Nebraska Medical Center, Omaha, NE 68198-6805, USA.
Experimental Biology and Medicine (Maywood, N.J.)
|April 21, 2010
Summary
Induced pluripotent stem (iPS) cells offer new avenues in regenerative medicine. Recent advancements have significantly improved our understanding and generation of these reprogrammed somatic cells.
Area of Science:
- Regenerative Medicine
- Stem Cell Biology
- Cellular Reprogramming
Background:
- Somatic cell reprogramming to induced pluripotent stem (iPS) cells marked a significant breakthrough.
- The field has seen rapid progress in characterizing iPS cells and optimizing their generation protocols.
Purpose of the Study:
- To provide an overview of iPS cell generation strategies.
- To highlight recent developments in iPS cell research.
- To discuss emerging unanswered questions in somatic cell reprogramming.
Main Methods:
- Review of existing literature on iPS cell generation.
- Analysis of recent studies focusing on iPS cell characterization and application.
- Identification and discussion of key challenges and future directions in the field.
Main Results:
- Significant expansion of knowledge regarding iPS cell properties and generation methods in the past year.
- Diverse strategies for generating iPS cells have been developed and refined.
- Emerging research is beginning to address fundamental questions in somatic cell reprogramming.
Conclusions:
- Induced pluripotent stem cells represent a transformative technology in regenerative medicine.
- Continued research is crucial for fully understanding and utilizing the potential of iPS cells.
- Addressing fundamental questions in reprogramming is key to future therapeutic applications.
Related Concept Videos
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:29Somatic to iPS Cell Reprogramming
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...